Results from our content library
AI-Powered Search
Sign in to search for any topic in our content library — get summaries, related past year questions, and practice MCQs on the topic.
Sign in to searchIndia Needs Innovative Strategies to Eliminate Tuberculosis (TB)
The Indian Council of Medical Research (ICMR) has reported encouraging results from the PreVenTB Phase III clinical trial, showing that two indigenous vaccines—VPM1002 and Immuvac—provide significant protection against extrapulmonary tuberculosis (EPTB), offering new hope in India's fight against TB.
Salient Points
Tuberculo
Sign up free to read the full article
Access all current affairs, state notes, subject notes and more — completely free.
ICMR's PreVenTB trial shows VPM1002 and Immuvac vaccines offer 50%+ protection against extrapulmonary TB. India advances toward 2025 TB elimination target.
Keywords